Evidence-Based Medicine Guidelines
Risedronate for the prevention of osteoporotic fractures in postmenopausal women
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women.
Risedronate for the prevention of osteoporotic fractures in postmenopausal women. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women. Accessed October 6, 2024.
Risedronate for the prevention of osteoporotic fractures in postmenopausal women. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women
Risedronate for the Prevention of Osteoporotic Fractures in Postmenopausal Women [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 October 06]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Risedronate for the prevention of osteoporotic fractures in postmenopausal women
ID - 452601
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/452601/all/Risedronate_for_the_prevention_of_osteoporotic_fractures_in_postmenopausal_women
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
